Sunday, January 07, 2018 3:48:02 PM
3D Signatures bullish profile in Tailwinds Research for 2018
By Daniel Carlson - January 5, 2018
3-D Signatures (DXD.V): for 3DS, 2017 was a year to forget. The stock went down dramatically on the back of a very poor financing effort. However, like the Phoenix, sometimes big disasters can turn into outstanding revivals. 3DS is poised to enter into several partnerships for its interesting technology. Meanwhile, the stock’s valuation discounts all success. I expect shares to advance in lockstep with the company’s development of their telomere technology and for 2018 to mark a dramatic turnaround for the Company.
http://bit.ly/2D4nUUc
By Daniel Carlson - January 5, 2018
3-D Signatures (DXD.V): for 3DS, 2017 was a year to forget. The stock went down dramatically on the back of a very poor financing effort. However, like the Phoenix, sometimes big disasters can turn into outstanding revivals. 3DS is poised to enter into several partnerships for its interesting technology. Meanwhile, the stock’s valuation discounts all success. I expect shares to advance in lockstep with the company’s development of their telomere technology and for 2018 to mark a dramatic turnaround for the Company.
http://bit.ly/2D4nUUc
Recent TDSGF News
- Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma • Newsfile • 04/14/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman • Newsfile • 03/31/2026 11:00:00 AM
- Telo Genomics Announces Appointment of John Price as Chief Financial Officer • Newsfile • 01/29/2026 01:00:00 PM
- Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program • Newsfile • 12/18/2025 09:05:00 PM
- Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting • Newsfile • 12/11/2025 09:00:00 PM
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 12/10/2025 02:57:30 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th • GlobeNewswire Inc. • 12/08/2025 01:35:00 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/05/2025 01:35:00 PM
- Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025 • Newsfile • 11/13/2025 01:30:00 PM
- American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition • Newsfile • 10/09/2025 12:30:00 PM
- Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update • Newsfile • 09/30/2025 08:30:00 PM
